Previous research has shown the health effects of obesity, including the decline in lung function. New research highlights obesity is a risk factor for asthma and chronic obstructive pulmonary disease in premenopausal and postmenopausal women.
In premenopausal and postmenopausal women, obesity and abdominal obesity, as measured by body mass index (BMI) and waist circumference (WC), are risk factors for asthma and chronic obstructive pulmonary disease (COPD), according to a study published in Menopause.
Previous studies have shown that women experience greater lung function impairment and have a higher risk of developing COPD than men. In addition, female smokes experience a more rapid decline in lung function between the ages of 45 and 50 years compared with male smokers.
While research has shown obesity leads to a decline in lung function and the incidence of COPD in people with obesity is significantly higher than those without, little is known about the effects of obesity on COPD and asthma in women relative to menopause.
“This study highlights yet another detrimental effect of obesity and abdominal adiposity in women and specifically identified that women with a high BMI and/or WC had a greater risk of developing COPD and asthma,” Stephanie Faubion, MD, MBA, FACP, NCMP, professor and chair of the Department of Medicine at Mayo Clinic in Jacksonville, Florida, said in a statement. “In addition to avoiding tobacco use, maintaining a healthy body weight and composition may help reduce the incidence of COPD and asthma in women.
Faubion is also the medical director of the North American Menopause Society (NAMS). Menopause, which published the study, is the journal of NAMS.
The nationwide population-based cohort study included 1,644,635 Korean women 30 years or older. The women did not have a diagnosis of COPD or asthma but had undergone national cancer screening in 2009. Their classification of premenopausal or postmenopausal was based on their status at the time of cancer screening.
Baseline BMI and WC were measured to classify the women in 5 BMI groups and 5 WC groups:
The researchers found that the groups with high BMI and WC had significantly higher COPD and asthma incidence compared with groups with normal BMI and WC regardless of menopausal status. The higher the BMI and WC, the greater the risk of both COPD and asthma. However, being underweight was also a risk factor for COPD in postmenopausal women.
“Controlling weight and maintaining a healthy body shape can help prevent COPD and asthma in women,” the authors concluded.
Reference
Lee C-W, Kim HJ, Nam MJ, et al. Obesity and abdominal obesity are risk factors for airway obstructive diseases in Korean women. Menopause. Published online February 21, 2022. doi:10.1097/GME.0000000000001958
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More